CHIRON CAPITAL MANAGEMENT, LLC

Position in SNY — Sanofi

CIK 1830922 TALLAHASSEE, FL

Position in SNY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$644,251

+$229,807 QoQ

Shares Held

15,102

+75.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#299

of 712 holders

Holding Since

Mar 2023

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $16,063,883 across 6 Drug Manufacturers - General names. SNY ranks #4 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	206,970	$11,925,611
2	PFE	Pfizer Inc	67,214	$1,618,513
3	GILD	Gilead Sciences, Inc.	8,080	$1,020,827
4	SNY	Sanofi This page	15,102	$644,251
5	NVO	Novo Nordisk A S	12,931	$619,912
6	MRK	Merck & Co., Inc.	1,827	$234,769

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$644,251	15,102	+75.6%	Shares	Sole	2026-07-21
2026-03-31	$414,444	8,602	+19.4%	Shares	Sole	2026-04-21
2024-12-31	$347,448	7,204	+89.6%	Shares	Sole	2025-02-13
2023-03-31	$206,796	3,800	—	Shares	Sole	2023-04-21
No filing history on record for this holder in this stock.